|
⚲
|
| Keyboard |
| Denise Barbut | |
|---|---|
| Firm | |
| Address | c/o Issuer, 2005 Market Street Suite 3125 Philadelphia, PA 19103 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Enterin Inc | 021-458578 | Executive Officer | 6.0 M of 20.0 M |
||
| Enterin Inc | 021-416388 | Executive Officer | 5.7 M of 32.0 M |
||
| Enterin Inc | 021-375633 | Executive Officer | 11.7 M of 20.0 M |
||
| Enterin Inc | 021-331463 | Executive Officer | 16.7 M of 25.0 M |
||
| Enterin Inc | 021-290794 | Executive Officer | 5.5 M of 12.7 M |
||
| Novo Biosciences Inc | 021-243877 | Director | 0.1 M of 1.0 M |
||
| Sarentis Therapeutics Inc | 021-243210 | Executive Officer | 0.8 M of 1.0 M |
||
| Clepsydra Inc | 021-187744 | Executive Officer | 0.3 M of 0.5 M |
||
| Enigma Medical Inc | 021-187746 | Executive Officer | 0.3 M of 0.5 M |
||
| Astuce Inc | 021-187742 | Executive Officer | 0.6 M of 1.0 M |
||
| Sarentis Ophthalmic Inc | 021-172966 | Executive Officer | 0.4 M of 0.4 M |
||
| Benechill Inc | 021-170022 | Director | 14.8 M of 25.6 M |
||
| Benechill Inc | 021-150446 | Director | 0.6 M of 1.2 M |
||
| Sarentis Therapeutics Inc | 021-136444 | Executive Officer | 3.6 M of 3.6 M |
||
| Benechill Inc | 021-88268 | Executive Officer | 13.7 M of 13.7 M |
||
| Coaxia Inc | 021-43710 | Director | 22.5 M of 22.5 M |
||
| Sabal Investment Advisors LLC | |||||
| SIA Debt Opportunities Fund LP | 021-187745 | Executive Officer | 0.3 M of 0.5 M |
96.3 M | |